EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC - Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP®).
暂无分享，去创建一个
I. Petersen | M. Tiemann | M. Mireskandari | A. Warth | W. Weichert | P. Schirmacher | M. Dietel | W. Geilenkeuser | F. Lasitschka | S. Reu | R. Büttner | H. Kreipe | K. Steiger | H. Schildhaus | F. Länger | T. Kirchner | K. Jöhrens | A. Scheel | C. Schulte